Detalhe da pesquisa
1.
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
Breast Cancer Res Treat
; 203(3): 497-509, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938495
2.
Essential medicines list in national cancer control plans: a secondary analysis from a global study.
Lancet Oncol
; 23(3): e144-154, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240089
3.
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Sci Immunol
; 9(92): eadg7995, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306416
4.
Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.
Lung Cancer
; 172: 94-99, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030612